Navigation Links
OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer
Date:6/21/2010

BOTHELL, WA, and VANCOUVER, June 21 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC). This trial, referred to as the Prostate Cancer SATURN Trial, is the first of three Phase 3 trials to be initiated under a global collaboration and license agreement between OncoGenex and Teva Pharmaceutical Industries (NASDAQ: TEVA) to develop and commercialize OGX-011/ TV-1011.

This randomized, controlled, international Phase 3 trial will be conducted in approximately 50 cancer centers and will enroll approximately 300 men with metastatic CRPC who have previously responded to first-line docetaxel therapy, but subsequently have disease progression that involves prostate cancer-related pain despite opioid usage. Patients will be randomized to receive retreatment with docetaxel/prednisone plus OGX-011/ TV-1011 or docetaxel/prednisone plus placebo in a blinded manner. The primary endpoint of the SATURN trial will be to determine whether durable pain palliation for 12 weeks or more is observed in a greater proportion of patients treated with docetaxel/prednisone plus OGX-011/ TV-1011 compared to docetaxel/prednisone plus placebo.

More information on the Prostate Cancer SATURN Trial is available on the Company's website at http://oncogenex.com/clinic
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... ALTO, Calif. , May 17, 2013 /PRNewswire/ ... it has achieved 50% enrollment of the total ... to evaluate the safety and preliminary efficacy of ... Cells) therapy for Knee Osteoarthritis (KOA). To date ... (SAE) reported. The Phase I open ...
(Date:5/17/2013)... Miami, FL (PRWEB) May 17, 2013 Men’s ... at La-roche Posay ) and has been known ... itself. Although some men may be far from puberty, other ... be clogging pores, causing breakouts, and threatening skin with unsightly ... with advice from Men’s Health on how to ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 IAC Industries wants ... a start up laboratory needing to set up and furnish ... to a larger facility within a year’s time. How does ... that the laboratory is temporary? What is efficient and cost-effective? ... modular workstations from IAC Industries. The planners at DisperSol determined ...
(Date:5/16/2013)... PA (PRWEB) May 16, 2013 Oven ... pid temperature controllers and temperature sensors since 1964. ... widely used in industrial control system applications. ... the device includes a generic, control loop feedback system, ... are expertly used to adjust a systematic process, using ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2New PID Temperature Controllers Announced by Oven Industries Inc. 2
... Executive Club of Chicago's annual forecast for this year, ... and look at the foreclosures on houses. You would think that ... would start to be more financially secure, but it does not ... up, the tech sector is still spotty with stocks like ...
... largest corporations could be big financial winners following the latest ... modified software. , ,The state Court of Appeals ... has been incorrectly taxing business software and will have to ... ,And even though Gov. Jim Doyle , facing a ...
... still in January, it is a good time to look ... that shaped the biotech industry and its development, particularly in ... biofuels, stem cells, BIO 2006 in Chicago, the reshaping and ... of Indian pharma, Food and Drug Administration product ...
Cached Biology Technology:Real pulse of the economy? Check real estate foreclosures 2Real pulse of the economy? Check real estate foreclosures 3Real pulse of the economy? Check real estate foreclosures 4Real pulse of the economy? Check real estate foreclosures 5Software tax dispute could go the Supreme Court 2Software tax dispute could go the Supreme Court 3The 10 biggest events shaping biotech in 2006 2The 10 biggest events shaping biotech in 2006 3The 10 biggest events shaping biotech in 2006 4The 10 biggest events shaping biotech in 2006 5The 10 biggest events shaping biotech in 2006 6The 10 biggest events shaping biotech in 2006 7The 10 biggest events shaping biotech in 2006 8
(Date:5/18/2013)... 18, 2013) Research presented at Digestive Disease ... health through diet and lifestyle. , Individuals ... reduced muscle strength, fatigue and poor quality of ... are in remission. A randomized, double blind, placebo-controlled ... D supplementation corresponded to significant relief of these ...
(Date:5/17/2013)... Jersey, and City University of New York have invented ... effectively clears organisms to be viewed under microscopes. Visikol ... is one of the few high-quality clearing solutions currently ... Enforcement Administration (DEA) due to its use as a ... for viewing organisms under a microscope. Without them, microscope ...
(Date:5/17/2013)... in Efficient and Sustainable Global Logistics Operations) is aiming ... the efficiency of intermodal loading systems and the boosting ... 29 European organisations with experience in the logistics sector ... totalling 17,000,000 and a duration of three and a ... develop the semantic components and ontologies shared by the ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3New logistics services that will cut energy consumption and CO2 emissions 2
... Branch at Galveston (UTMB) have identified a key biochemical connection ... molecular mechanism is similar to the one that links the ... cervical cancer, according to Dr. Stanley M. Lemon, the senior ... published this week in the online early edition of the ...
... its existence to tiny microorganisms living in the oceans, ... services these microbes perform for the planet remains largely ... Academy of Microbiology, entitled Marine Microbial Diversity: The Key ... in the oceans, marine microorganisms are the closest living ...
... Energy's Argonne National Laboratory have found elevated amounts of ... Ludwig von Beethoven, consistent with their earlier finding of ... results confirm the cause of his years of chronic ... testing to have come from Beethoven's body, were scanned ...
Cached Biology News:Texas scientists discover how a hepatitis C protein promotes liver cancer 2Understanding the oceans microbes is key to the Earth's future 2Argonne researchers confirm lead in Beethoven's illness 2Argonne researchers confirm lead in Beethoven's illness 3
... In 1959, McCoy and his ... requirements for in vitro cultivation ... studies were performed using,Basal Medium ... create a new medium known ...
... is a 12 amino acid synthetic peptide whose sequence is ... peptide is (amino to carboxy terminus): C - S(338) ... - Q - V - A - P - A(348). ... control experiments with the polyclonal antibody that reacts with this ...
... IRsolution software provides quick and easy ... functions with Windows-based control. The software ... and FDA 21 CFR Part 11 regulations, ... of measurement. IRsolutions versatility enables use ...
... PerkinElmer kit provides reagents for immune complex ... and plasma samples using a combination of ... then neutralized and transferred to microplate wells ... mouse monoclonal antibody to HIV-1 p24. The ...
Biology Products: